An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults

Please cite this paper as: Talaat et al. (2012) An open‐label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults. Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750‐2659.2012.00350.x. Background  Live attenuated influenza vaccines (LAIV) against a variety of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Talaat, Kawsar R., Karron, Ruth A., Liang, Philana H., McMahon, Bridget A., Luke, Catherine J., Thumar, Bhagvanji, Chen, Grace L., Min, Ji‐Young, Lamirande, Elaine W., Jin, Hong, Coelingh, Kathy L., Kemble, George W., Subbarao, Kanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527634/
https://www.ncbi.nlm.nih.gov/pubmed/22417012
http://dx.doi.org/10.1111/j.1750-2659.2012.00350.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527634/
https://www.ncbi.nlm.nih.gov/pubmed/22417012
http://dx.doi.org/10.1111/j.1750-2659.2012.00350.x

Ejemplares similares